GEP19991778B - Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation - Google Patents

Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation

Info

Publication number
GEP19991778B
GEP19991778B GEAP19963947A GEAP1996003947A GEP19991778B GE P19991778 B GEP19991778 B GE P19991778B GE AP19963947 A GEAP19963947 A GE AP19963947A GE AP1996003947 A GEAP1996003947 A GE AP1996003947A GE P19991778 B GEP19991778 B GE P19991778B
Authority
GE
Georgia
Prior art keywords
schizophasia
preparation
bemzodiazepine
thieno
oral
Prior art date
Application number
GEAP19963947A
Inventor
Tommy C Morris
George R Cochram
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to GEAP19963947A priority Critical patent/GEP19991778B/en
Publication of GEP19991778B publication Critical patent/GEP19991778B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Simplification of chemical processes and increase in activity and metastability of the compounds. 2. Essence Preparation of olanzapine for peroral administration which comprises a bulking agent, a binder, a disintegrant, a lubricant and additionally a polymer coating selected from the group consisting of hydroxypropyl methylcellulose, hydroxyethyl cellulose, methylhydroxyethylcellulose, polyvinyl pyrrolidone, acrylic acid, dimethylaminoethyl metacrylatemethylacrylate acid ester copolymer, methylcellulose and ethylcellulose, process for its production and use against psychosis, schizophasia, schizophasia-like disorders, slight anxieties, gastro-intestinal disturbances and acute maniacal syndromes. 3. Field of Application Chemistry, in particular organic chemistry, medicine. 3 ind. 14 dep. cl.
GEAP19963947A 1996-03-22 1996-03-22 Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation GEP19991778B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP19963947A GEP19991778B (en) 1996-03-22 1996-03-22 Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP19963947A GEP19991778B (en) 1996-03-22 1996-03-22 Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation

Publications (1)

Publication Number Publication Date
GEP19991778B true GEP19991778B (en) 1999-10-05

Family

ID=81852037

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19963947A GEP19991778B (en) 1996-03-22 1996-03-22 Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation

Country Status (1)

Country Link
GE (1) GEP19991778B (en)

Similar Documents

Publication Publication Date Title
SE9703206D0 (en) Oral composition containing olanzapine and process for its preparation
AU646399B2 (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
NZ336251A (en) Composition comprising a core layer (active ingredient, hydroxypropyl cellulose and microcrystalline cellulose), an inner layer (such as hydroxypropylmethyl cellulose, polyvinyl pyrolidore and lubricants; magnesium stearate or talc), an outer layer (hydroxypropylmethyl and hydroxypropyl cellulose)
CA2041774A1 (en) Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
HUP9702114A3 (en) Process for the coating of objects with hyaluronic acid, derivatives thereof, and semisynthetic polymers
CA2186039A1 (en) New oral pharmaceutical dosage form
CA2306103A1 (en) Novel once-a-day controlled release sulfonylurea formulation
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
IL142474A0 (en) Pharmaceutical formulation comprising omeprazole
NO20001624D0 (en) Sustained-release tablet formulation for the treatment of Parkinson's disease
DK0923934T3 (en) Modified release matrix formulation of cefaclor and cephalexin
GB9025372D0 (en) Pharmaceutical dosage forms
AU6611396A (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
PL310298A1 (en) Pharmaceutic agent of prolonged g-pyrone release
CA2150162A1 (en) New n-pyridyl carboxamides and derivatives thereof, preparation processes thereof and pharmaceutical compositions containing thereof
GR1003658B (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
NZ515339A (en) Use of macrolide compounds for the treatment of dry eye
CA2241014A1 (en) Morphine derivatives with analgesic activity
ATE235901T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3-(2,2,2-TRIMETHYLHYDRAZINIUM)PROPRIONATE AND GAMMA-BUTYROBETAIN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
GEP19991778B (en) Oral 2-Methyl-Thieno-Bemzodiazepine Formulation and Process for is Preparation
MD1744F2 (en) Clavulanates and process for preparation thereof
ZA968762B (en) Derivatives of acid pyrazoles, their preparation process, their use as medicaments, their new use and the pharmaceutical compositions containing them.
AU660296B2 (en) Pharmaceutical compositions containing functionalized vinylazoles, use of these vinylazoles for producing medicaments, these vinylazoles themselves and process for producing the same
HUP9900642A3 (en) 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation, process for producing them and their use for producing pharmaceutical compositions
ATE226582T1 (en) PYRROLO(3,4-B)QUINOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING SAME